Literature DB >> 20686453

Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function.

Matthew T James1, William A Ghali, Marcello Tonelli, Peter Faris, Merril L Knudtson, Neesh Pannu, Scott W Klarenbach, Braden J Manns, Brenda R Hemmelgarn.   

Abstract

To determine whether acute kidney injury results in later long-term decline in kidney function we measured changes in kidney function over a 3-year period in adults undergoing coronary angiography who had serum creatinine measurements as part of their clinical care. Acute kidney injury was categorized by the magnitude of increase in serum creatinine (mild (50-99% or >or=0.3 mg/dl) and moderate or severe (>or=100%)) within 7 days of coronary angiography. Compared to patients without acute kidney injury, the adjusted odds of a sustained decline in kidney function at 3 months following angiography increased more than 4-fold for patients with mild to more than 17-fold for those with moderate or severe acute kidney injury. Among those with an estimated glomerular filtration rate after angiography less than 90 ml/min per 1.73 m(2), the subsequent adjusted mean rate of decline in estimated glomerular filtration rate during long-term follow-up (all normalized to 1.73 m(2) per year) was 0.2 ml/min in patients without acute kidney injury, 0.8 ml/min following mild injury, and 2.8 ml/min following moderate to severe acute kidney injury. Thus, acute kidney injury following coronary angiography is associated with a sustained loss and a larger rate of future decline in kidney function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686453     DOI: 10.1038/ki.2010.258

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  92 in total

1.  Incidence, determinants and impact of acute kidney injury in patients with diabetes mellitus and multivessel disease undergoing coronary revascularization: Results from the FREEDOM trial.

Authors:  Yaron Arbel; Valentin Fuster; Usman Baber; Taye H Hamza; F S Siami; Michael E Farkouh
Journal:  Int J Cardiol       Date:  2019-06-13       Impact factor: 4.164

2.  Acute kidney injury as an independent predictor of infection and malignancy: the NARA-AKI cohort study.

Authors:  Miho Tagawa; Masatoshi Nishimoto; Maiko Kokubu; Masaru Matsui; Masahiro Eriguchi; Ken-Ichi Samejima; Yasuhiro Akai; Kazuhiko Tsuruya
Journal:  J Nephrol       Date:  2019-10-15       Impact factor: 3.902

3.  Are we still wondering or wandering in the dark?

Authors:  Davide Cattano
Journal:  Intern Emerg Med       Date:  2011-03-17       Impact factor: 3.397

4.  AKI and medical care after coronary angiography: renalism revisited.

Authors:  Steven D Weisbord
Journal:  Clin J Am Soc Nephrol       Date:  2014-10-15       Impact factor: 8.237

Review 5.  Contrast medium induced acute kidney injury: a narrative review.

Authors:  Valentina Pistolesi; Giuseppe Regolisti; Santo Morabito; Ilaria Gandolfini; Silvia Corrado; Giovanni Piotti; Enrico Fiaccadori
Journal:  J Nephrol       Date:  2018-05-25       Impact factor: 3.902

6.  Do children with acute kidney injury require long-term evaluation for CKD?

Authors:  David J Askenazi
Journal:  Am J Kidney Dis       Date:  2012-04       Impact factor: 8.860

Review 7.  Recent advances in acute kidney injury epidemiology.

Authors:  Edward D Siew; Serpil M Deger
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-05       Impact factor: 2.894

Review 8.  Linking acute kidney injury to chronic kidney disease: the missing links.

Authors:  Mohammed A Kaballo; Mohamed E Elsayed; Austin G Stack
Journal:  J Nephrol       Date:  2016-12-07       Impact factor: 3.902

9.  Limb ischemia protects against contrast-induced nephropathy.

Authors:  Joseph V Bonventre
Journal:  Circulation       Date:  2012-06-26       Impact factor: 29.690

Review 10.  Chronic kidney disease following acute kidney injury-risk and outcomes.

Authors:  Kelvin C W Leung; Marcello Tonelli; Matthew T James
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.